Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Pashtoon M. Kasi"'
Autor:
Ana P. Lucas, MD, Andrew R. Lewis, MD, Pashtoon M. Kasi, MD, Beau B. Toskich, MD, Ricardo Paz-Fumagalli, MD
Publikováno v:
Radiology Case Reports, Vol 19, Iss 3, Pp 910-914 (2024)
The abscopal effect is a rare phenomenon characterized by disease regression in distant sites after tumoral locoregional therapy. Locoregional therapy, such as cryoablation, can induce an antitumor immunological response, potentially improving outcom
Externí odkaz:
https://doaj.org/article/89c36c4aae584cedba4e8d0b19c15190
Autor:
Fang-Shu Ou, Daniel H. Ahn, Jesse G. Dixon, Axel Grothey, Yiyue Lou, Pashtoon M. Kasi, Joleen M. Hubbard, Eric Van Cutsem, Leonard B. Saltz, Hans-Joachim Schmoll, Richard M. Goldberg, Alan P. Venook, Paulo Hoff, Jean-Yves Douillard, J. Randolph Hecht, Herbert Hurwitz, Cornelis J. A. Punt, Miriam Koopman, Carsten Bokemeyer, Charles S. Fuchs, Eduardo Diaz-Rubio, Niall C. Tebbutt, Chiara Cremolini, Fairooz F. Kabbinavar, Tanios Bekaii-Saab, Benoist Chibaudel, Takayuki Yoshino, John Zalcberg, Richard A. Adams, Aimery de Gramont, Qian Shi
Publikováno v:
Cancers, Vol 15, Iss 16, p 4117 (2023)
Metastatic colorectal cancer (mCRC) is a heterogeneous disease that can evoke discordant responses to therapy among different lesions in individual patients. The Response Evaluation Criteria in Solid Tumors (RECIST) criteria do not take into consider
Externí odkaz:
https://doaj.org/article/ce222f9467be42278701433a1ee37c17
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 18, Iss 1, Pp 1-5 (2020)
Abstract Background Patients with DNA-damage response genes (DDR)-related pancreas cancer (BRCA1/2 or other DNA-damage related genes) may have improved outcomes secondary to increased sensitivity to DNA-damaging drugs (platinum chemotherapy/ poly ADP
Externí odkaz:
https://doaj.org/article/af6640538cb74f839d14303db0dc2ff0
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 1, Pp 98-103 (2019)
The field of theranostics is a new nuclear medicine tool being utilized in the treatment of different types of cancers. It couples receptor-specific based imaging predicting and guiding response to receptor-specific based radionuclide therapies. For
Externí odkaz:
https://doaj.org/article/7d1770d4c5f34ebd9a649654be5e3d53
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 3, Pp 1144-1149 (2017)
Neuroendocrine tumors (NETs) are rare malignancies that usually arise from the digestive tract or lungs. Metastases of NETs to the heart (epicardium) are a rare complication. We present a case of a metastatic NET involving the epicardium.
Externí odkaz:
https://doaj.org/article/ec02890f496445ecbf8b1e9156f53ae4
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Liquid biopsies (circulating tumor DNA—ctDNA testing) are increasingly being utilized in clinical trials as well as practice for the detection of cancer, monitoring of tumor genomic abnormalities, response to treatment and early detection of relaps
Externí odkaz:
https://doaj.org/article/2fb090df483d40eba42fab800e5ea4f3
Autor:
Cassia B. Wang, Faisal Shahjehan, Amit Merchea, Zhuo Li, Tanios S. Bekaii-Saab, Axel Grothey, Dorin T. Colibaseanu, Pashtoon M. Kasi
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Background: Our study investigated the demographic characteristics of Mayo Clinic Colon and Rectal Cancer Registry patients and sought to associate tumor location with overall survival.Methods: Using the cohort of patients seen at Mayo Clinic (Minnes
Externí odkaz:
https://doaj.org/article/3132622d539a4ee69fd4e2e79b4af08b
Publikováno v:
Leukemia Research Reports, Vol 5, Iss C, Pp 7-10 (2016)
For acute myeloid leukemia (AML), identification of activating mutations in the FMS-like tyrosine kinase-3 (FLT3) has led to the development of several FLT3-inhibitors. Here we present clinical and next generation sequencing data at the time of progr
Externí odkaz:
https://doaj.org/article/108a8684eecd4df59bc2a11edaea8f15
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Discovery of a hereditary cancer syndrome can be one of the factors that determine whether a healthy individual completes pancreas cancer screening or whether an individual with cancer receives certain chemotherapies. Retrospective review was complet
Externí odkaz:
https://doaj.org/article/271404e844d24539ae0a09dfd6aa4705
Autor:
Alexandra W. Elias, Pashtoon M. Kasi, John A. Stauffer, David D. Thiel, Dorin T. Colibaseanu, Kabir Mody, Richard W. Joseph, Sanjay P. Bagaria
Publikováno v:
Frontiers in Oncology, Vol 7 (2017)
Immune checkpoint inhibitors (ICI) are revolutionizing care for cancer patients. The list of malignancies for which the Food and Drug Administration is granting approval is rapidly increasing. Furthermore, there is a concomitant increase in clinical
Externí odkaz:
https://doaj.org/article/5966e00a90a74bc0a4dd5aa3863ad880